Dibucaine Ointment
NDC Package 71399-2829-2
Package Information
Dibucaine ointment is not for prolonged useAdults should not use more than 1oz in 24 hours or 1/4 oz for childApply to affected area 3 or 4 times dailyCover with light dressing, if necessary. This formulation utilizes a ointment delivery system. Marketed by Akron Pharma Inc., this product is identified by NDC 71399-2829 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 238784 - dibucaine 1 % Rectal Ointment
- RxCUI: 238784 - dibucaine 0.01 MG/MG Rectal Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71399 - Akron Pharma Inc.
- 71399-2829 - Dibucaine
- 71399-2829-2 - 1 TUBE in 1 PACKAGE / 56 g in 1 TUBE
- 71399-2829 - Dibucaine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71399-2829). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71399-2829-2 identifies a specific commercial package of 1 tube in 1 package / 56 g in 1 tube of Dibucaine, a human over the counter drug labeled by Akron Pharma Inc.. This product is billed per "GM" gram and contains an estimated amount of 56 billable units per package. This ointment is formulated for topical use and contains dibucaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Akron Pharma Inc. on January 06, 2025. The current certification is valid through December 31, 2026.
How is this Akron Pharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71399282902. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 56 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.